Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study

To investigate the direct medical costs for patients with type 2 diabetes in China and to examine the influencing factors.

[1]  Yichong Li,et al.  Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.

[2]  Ling Li,et al.  China's health care system reform: Progress and prospects , 2017, The International journal of health planning and management.

[3]  Gordon Liu,et al.  China's Health Reform Update. , 2017, Annual review of public health.

[4]  Yonghua Hu,et al.  Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China , 2017, Journal of diabetes.

[5]  Md. Nazmul Hassan,et al.  Association of good glycemic control and cost of diabetes care: Experience from a tertiary care hospital in Bangladesh. , 2016, Diabetes research and clinical practice.

[6]  M. Postma,et al.  Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data , 2016, PloS one.

[7]  D. Mauricio,et al.  Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain , 2015, The European Journal of Health Economics.

[8]  K. Secnik,et al.  Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes , 2005, Journal of managed care pharmacy : JMCP.

[9]  A Gray,et al.  The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[10]  M. Toh,et al.  Direct Medical Cost of Type 2 Diabetes in Singapore , 2015, PloS one.

[11]  Zhihong Wu,et al.  A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China , 2015, Diabetes Therapy.

[12]  J. Langer,et al.  Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States , 2014, Diabetes Therapy.

[13]  C. Huber,et al.  Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011 , 2014, BMC Endocrine Disorders.

[14]  Ž. Padaiga,et al.  Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. , 2014, Medicina.

[15]  I. Skrzekowska-Baran,et al.  Costs of diabetes and its complications in Poland , 2013, The European Journal of Health Economics.

[16]  Jesse C. Crosson,et al.  Medical costs associated with type 2 diabetes complications and comorbidities. , 2013, The American journal of managed care.

[17]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[18]  Wenying Yang,et al.  Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity , 2012, PloS one.

[19]  Young Seol Kim,et al.  Direct Medical Costs for Patients with Type 2 Diabetes and Related Complications: A Prospective Cohort Study Based on the Korean National Diabetes Program , 2012, Journal of Korean medical science.

[20]  Alan Maynard,et al.  Early appraisal of China's huge and complex health-care reforms , 2012, The Lancet.

[21]  R. Gomis,et al.  Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study , 2011, Diabetologia.

[22]  S. Chatterjee,et al.  Cost of diabetes and its complications in Thailand: a complete picture of economic burden. , 2011, Health and Social Care in the community.

[23]  F. Al-Maskari,et al.  Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates , 2010, BMC public health.

[24]  V. Viswanathan,et al.  The socioeconomics of diabetes from a developing country: a population based cost of illness study. , 2010, Diabetes research and clinical practice.

[25]  Biao Xu,et al.  Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China , 2010, BMC health services research.

[26]  Biao Xu,et al.  Type 2 diabetes mellitus in China: a preventable economic burden. , 2009, The American journal of managed care.

[27]  Biao Xu,et al.  How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[28]  M. Anvari,et al.  The economic costs of diabetes: a population-based study in Tehran, Iran , 2009, Diabetologia.

[29]  C. Collins,et al.  Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003 , 2007, BMC Health Services Research.

[30]  G. Olveira,et al.  Economic cost associated with type II diabetes in Spanish patients , 2006, The European Journal of Health Economics.

[31]  R. Donnelly,et al.  Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments. , 2006, British journal of clinical pharmacology.

[32]  H. Hauner,et al.  The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM Study , 2006, Diabetologia.

[33]  Morton B. Brown,et al.  The direct medical cost of type 2 diabetes. , 2003, Diabetes care.

[34]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[35]  K. Kissimova-Skarbek,et al.  [Evaluation of the burden of diabetes in Poland]. , 2001, Polskie Archiwum Medycyny Wewnetrznej.

[36]  C. Östenson,et al.  Direct medical costs for patients with type 2 diabetes in Sweden , 2000, Journal of internal medicine.

[37]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[38]  Mikel L. Forcada,et al.  ATLAS , 2011, EAMT.

[39]  A. Palmer,et al.  Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[40]  J. Leahy.  Economic Costs of Diabetes in the U.S. in 2007 , 2008 .